title: A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ.
abstract: Cannabinoid receptors (CB) are expressed throughout human skin epithelium. CB1 activation inhibits human hair growth and decreases proliferation of epidermal keratinocytes. Since psoriasis is a chronic hyperproliferative, inflammatory skin disease, it is conceivable that the therapeutic modulation of CB signaling, which can inhibit both proliferation and inflammation, could win a place in future psoriasis management. Given that psoriasis is characterized by up-regulation of keratins K6 and K16, we have investigated whether CB1 stimulation modulates their expression in human epidermis. Treatment of organ-cultured human skin with the CB1-specific agonist, arachidonoyl-chloro-ethanolamide (ACEA), decreased K6 and K16 staining intensity in situ. At the gene and protein levels, ACEA also decreased K6 expression of cultured HaCaT keratinocytes, which show some similarities to psoriatic keratinocytes. These effects were partly antagonized by the CB1-specific antagonist, AM251. While CB1-mediated signaling also significantly inhibited human epidermal keratinocyte proliferation in situ, as shown by K6/Ki-67-double immunofluorescence, the inhibitory effect of ACEA on K6 expression in situ was independent of its anti-proliferative effect. Given recent appreciation of the role of K6 as a functionally important protein that regulates epithelial wound healing in mice, it is conceivable that the novel CB1-mediated regulation of keratin 6/16 revealed here also is relevant to wound healing. Taken together, our results suggest that cannabinoids and their receptors constitute a novel, clinically relevant control element of human K6 and K16 expression.
authors: Department of Dermatology, University of Luebeck, Luebeck, Germany.|Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors: Yuval
authors: Y
authors: Ramot
authors: Department of Dermatology, University of Luebeck, Luebeck, Germany.|Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
authors: Koji
authors: K
authors: Sugawara
authors: Department of Dermatology, University of Luebeck, Luebeck, Germany.|DE-MTA "Lendület" Cellular Physiology Research Group, Department of Physiology, MHSC, RCMM, University of Debrecen, Debrecen, Hungary.
authors: Nóra
authors: N
authors: Zákány
authors: DE-MTA "Lendület" Cellular Physiology Research Group, Department of Physiology, MHSC, RCMM, University of Debrecen, Debrecen, Hungary.|Laboratory of Ion Channel Research and TRP Research Platform Leuven (TRPLe), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
authors: Balázs I
authors: BI
authors: Tóth
authors: DE-MTA "Lendület" Cellular Physiology Research Group, Department of Physiology, MHSC, RCMM, University of Debrecen, Debrecen, Hungary.
authors: Tamás
authors: T
authors: Bíró
authors: Department of Dermatology, University of Luebeck, Luebeck, Germany.|Institute of Inflammation and Repair, and Dermatology Centre, University of Manchester, Manchester, UK.
authors: Ralf
authors: R
authors: Paus
keywords: Cannabinoid; Keratin; Psoriasis; Wound healing
references: Br J Dermatol. 2006 Oct;155(4):688-94
references: 16965416
references: J Dermatol Sci. 2007 Feb;45(2):87-92
references: 17157480
references: Cancer Metastasis Rev. 2011 Dec;30(3-4):599-612
references: 22038019
references: Clin Exp Immunol. 2012 Sep;169(3):311-9
references: 22861371
references: Biochem Biophys Res Commun. 2010 Apr 16;394(4):928-33
references: 20233580
references: J Invest Dermatol. 2009 Feb;129(2):329-39
references: 18769453
references: Differentiation. 1989 Mar;40(1):42-54
references: 2472990
references: J Allergy Clin Immunol. 2012 Mar;129(3):726-738.e8
references: 22226549
references: Exp Dermatol. 2011 Oct;20(10):855-7
references: 21824198
references: Br J Pharmacol. 2011 Oct;164(3):1026-40
references: 21449913
references: J Cell Biol. 1988 Mar;106(3):761-71
references: 2450098
references: Arthritis Rheum. 2009 Apr;60(4):1129-36
references: 19333940
references: Life Sci. 2013 Mar 19;92(8-9):463-6
references: 23069587
references: Lancet. 2007 Jul 21;370(9583):263-271
references: 17658397
references: Pain. 1998 Mar;75(1):111-119
references: 9539680
references: Molecules. 2011 May 10;16(5):3908-32
references: 21555979
references: PLoS One. 2011;6(7):e22564
references: 21818338
references: J Biol Chem. 2012 May 4;287(19):15466-78
references: 22431736
references: J Biol Chem. 2011 Aug 12;286(32):27971-9
references: 21693703
references: Trends Pharmacol Sci. 2009 Aug;30(8):411-20
references: 19608284
references: Genet Mol Res. 2012 Feb 17;11(1):412-20
references: 22370944
references: J Cell Biol. 1984 Apr;98(4):1397-406
references: 6201492
references: Br J Dermatol. 2009 Oct;161(4):933-8
references: 19519832
references: J Invest Dermatol. 2011 May;131(5):1095-104
references: 21248768
references: Inflamm Res. 2001 Jan;50(1):44-9
references: 11235021
references: Exp Dermatol. 2009 Aug;18(8):669-79
references: 19664006
references: Hautarzt. 2006 Sep;57(9):801-7
references: 16874533
references: Int Rev Cytol. 2005;243:1-78
references: 15797458
references: Exp Dermatol. 2012 Mar;21(3):184-8
references: 22142393
references: J Eur Acad Dermatol Venereol. 2005 May;19(3):319-22
references: 15857457
references: J Invest Dermatol. 2012 Aug;132(8):1967-76
references: 22513781
references: J Biol Chem. 2003 Sep 5;278(36):33896-903
references: 12815050
references: Exp Dermatol. 2010 Feb;19(2):117-22
references: 19889021
references: FASEB J. 2008 Oct;22(10):3685-95
references: 18596221
references: J Clin Endocrinol Metab. 2012 Mar;97(3):978-86
references: 22259067
references: J Biol Chem. 2008 Mar 7;283(10):6005-12
references: 18165231
references: J Cell Biol. 2012 Apr 30;197(3):381-9
references: 22529101
references: Biochem Pharmacol. 2010 Jun 15;79(12):1815-26
references: 20206138
references: Exp Dermatol. 2012 Nov;21(11):865-70
references: 23163653
references: Gastroenterology. 2005 Aug;129(2):437-53
references: 16083701
references: Neurotoxicology. 2012 Jan;33(1):138-46
references: 22233683
references: Dermatology. 2000;201(1):15-20
references: 10971053
references: Science. 2007 Jun 8;316(5830):1494-7
references: 17556587
references: Exp Dermatol. 2011 Aug;20(8):627-32
references: 21539622
references: J Dermatol Sci. 2005 Jun;38(3):177-88
references: 15927811
references: Exp Dermatol. 2011 Aug;20(8):677-9
references: 21521372
references: Exp Dermatol. 2012 Nov;21(11):892-4
references: 23163661
references: Br J Dermatol. 2010 May;162(5):1127-31
references: 20302576
references: J Invest Dermatol. 2011 May;131(5):1029-36
references: 21191405
references: J Cell Biol. 1996 Feb;132(3):381-97
references: 8636216
references: Exp Dermatol. 2012 Jul;21(7):549-51
references: 22716254
references: Nat Rev Immunol. 2005 May;5(5):400-11
references: 15864274
references: J Invest Dermatol. 1991 May;96(5):724-8
references: 1708798
references: Exp Dermatol. 2007 Jan;16(1):37-44
references: 17181635
references: Assay Drug Dev Technol. 2010 Jun;8(3):389-400
references: 20482335
references: Exp Dermatol. 2012 Sep;21(9):688-93
references: 22897575
references: Endocrinology. 2010 Apr;151(4):1633-42
references: 20176727
references: J Invest Dermatol. 2011 May;131(5):1045-52
references: 21390048
references: Handb Exp Pharmacol. 2005;(168):509-54
references: 16596786
references: J Neurosci. 2012 May 16;32(20):7091-101
references: 22593077
references: J Biol Chem. 1995 Sep 8;270(36):21362-7
references: 7545670
references: J Dermatol. 2004 Apr;31(4):271-6
references: 15187321
references: Histochem Cell Biol. 2008 Jun;129(6):705-33
references: 18461349
references: Proc Natl Acad Sci U S A. 1981 Nov;78(11):6907-11
references: 6171824
references: FASEB J. 2010 May;24(5):1525-31
references: 20075194
references: J Clin Invest. 2003 Jan;111(1):43-50
references: 12511587
references: FASEB J. 2007 Nov;21(13):3534-41
references: 17567570
references: Neuropharmacology. 2012 Jan;62(1):192-9
references: 21736884
references: Pharmacol Rev. 2010 Dec;62(4):588-631
references: 21079038
references: Arch Dermatol Res. 1988;280(4):189-93
references: 3233011
references: FASEB J. 2010 Jun;24(6):1768-79
references: 20103718